Company profilePharmaceutical#491 of 1,318 in Pakistan✓ No DRAP alerts

MENDOZA

Pharmaceutical company · 28 brands · 60 molecules

Ranked #10 of 29 companies in Vitamin B Complex Plain & With Vitamin C

28 registered products 41 pharmaceutical brands 60 distinct molecules 0 DRAP alerts

Company overview

28
registered products
41
pharmaceutical brands
60
distinct molecules
11
therapeutic classes
0
DRAP alerts

MENDOZA is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 28 product registrations across 60 distinct molecules. Its portfolio is concentrated in Vitamin B Complex Plain & With Vitamin C and Antianemic, Iron & All Combination. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Top molecules by brand count

Nicotinamide5 brands
Pyridoxine5 brands
Riboflavin5 brands
Thiamine5 brands
Folic Acid2 brands
Silymarin2 brands
Lysine2 brands

Therapeutic classes

Vitamin B Complex Plain & With Vitamin C · 2Antianemic, Iron & All Combination · 2Agents Against Amoebiasis And Other Protozoal Diseases · 2Antianemic, Iron Preparations · 1Topical Products For Joint And Muscular Pain · 1Antihaemorrhagic · 1Antiinflammatory And Antirheumatic Products · 1Digestive Enzymes · 1Antibiotics For Topical Use · 1Antiseptics And Disinfectants · 1Macrolides, Lincosamides And Streptogramins · 1

Conditions treated

Liver/Kidney/Stone · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official7 products · Rs 198.92 – Rs 555.03
DVAGO9 products · Rs 56.56 – Rs 332.5
Servaid1 products · Rs 232.2 – Rs 232.2
Median across source: Rs 232.2

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Get the full profile for MENDOZA

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.